Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.77 |
| ▸ | NPC1 | O15118 | 5/20 | 0.77 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | POLB | P06746 | 2/20 | 0.71 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.70 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.67 |
| ▸ | CA12 | O43570 | 1/20 | 0.67 |
| ▸ | CA1 | P00915 | 1/20 | 0.67 |
| ▸ | IDO1 | P14902 | 1/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.67 |
| ▸ | CA9 | Q16790 | 1/20 | 0.67 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.67 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.67 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12324391 | 0.97 | RAB9A (0.82) | RAB9ANPC1CTDSP1KDM4EPOLB | |
| SCHEMBL28875360 | 0.92 | SMN1; SMN2 (0.71) | RAB9ANPC1CTDSP1KDM4EPOLB | |
| SCHEMBL3724445 | 0.92 | RAB9A (0.68) | RAB9ANPC1CTDSP1KDM4EPOLB | |
| SCHEMBL10309466 | 0.90 | SMN1; SMN2 (0.74) | RAB9ANPC1CTDSP1KDM4EPOLB | |
| SCHEMBL2897981 | 0.90 | RAB9A (0.65) | RAB9ANPC1CTDSP1KDM4EPOLB | |
| Malonic Acid SCHEMBL30274338 | 0.90 | RAB9A (0.65) | RAB9ANPC1CTDSP1KDM4EPOLB | |
| SCHEMBL6963750 | 0.90 | RAB9A (0.65) | RAB9ANPC1CTDSP1KDM4EPOLB | |
| SCHEMBL16438824 | 0.89 | HDAC3 (0.68) | RAB9ANPC1CTDSP1KDM4EPOLB | |
| SCHEMBL13454574 | 0.88 | RAB9A (0.63) | RAB9ANPC1CTDSP1KDM4EPOLB | |
| SCHEMBL11298577 | 0.88 | RAB9A (0.75) | RAB9ANPC1CTDSP1KDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3428229-B1 | CURABLE RESIN COMPOSITION, FUEL CELL, AND SEALING METHOD | THREE BOND CO LTD (JP) | 2022-08-17 | — | — | EP | claimed |
| US-10800952-B2 | Curable resin composition, fuel cell, and sealing method | THREEBOND CO., LTD. (JP) | 2020-10-13 | — | — | US | claimed |
| EP-1928844-A2 | BIS-ARYL AMIDE COMPOUNDS AND METHODS OF USE | Amgen, Inc (US) | 2008-06-11 | — | — | EP | claimed |
| WO-2007022380-A2 | BIS-ARYL AMIDE COMPOUNDS AND METHODS OF USE | AMGEN INC. (US) | 2007-02-22 | — | — | WO | claimed |
| EP-1135363-B1 | PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES | GREAT LAKES CHEMICAL EUROP (CH) | 2003-09-24 | — | — | EP | claimed |
| US-6444848-B1 | REACTING HYDRAZINE WITH ACID CHLORIDE | GREAT LAKES CHEMICAL (EUROPE) GMBH (DE) | 2002-09-03 | — | — | US | claimed |
| EP-1135363-A1 | PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES | Great Lakes Chemical (Europe) GmbH (CH) | 2001-09-26 | — | — | EP | claimed |
| WO-2000034227-A1 | PROCESS FOR THE PREPARATION OF SYMMETRICAL DIACYLHYDRAZINES | GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) | 2000-06-15 | — | — | WO | claimed |
| EP-0909788-A1 | RUBBER COMPOSITION AND PNEUMATIC TIRES | Bridgestone Corporation (JP) | 1999-04-21 | — | — | EP | claimed |
| US-4371602-A | Photosensitive printing plate | TOKYO OHKA KOGYO CO., LTD. (JP) | 1983-02-01 | — | — | US | claimed |
| JP-8020580-A | — | — | None | — | — | JP | disclosed |
| US-20260138359-A1 | SILICONE-THERMOPLASTIC COMPOSITE ARTICLES | DOW SILICONES CORP (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260109818-A1 | LIQUID SILICONE RUBBER COMPOSITION | DOW SILICONES CORP (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260098144-A1 | RESIN COMPOSITION, FILM WITH RESIN, PREPREG, SHEET OF METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2026-04-09 | — | — | US | disclosed |
| EP-4590759-A1 | SILICONE-THERMOPLASTIC COMPOSITE ARTICLES | Dow Silicones Corporation (US) | 2025-07-30 | — | — | EP | disclosed |
| US-4338244-A | HEAT AND OXIDATION RESISTANT POLYMERS | SANDOZ LTD. (CH) | 1982-07-06 | — | — | US | disclosed |
| US-4325863-A | POLYMERS | SANDOZ LTD. (CH) | 1982-04-20 | — | — | US | disclosed |
| US-4052362-A | N-CINNAMOYL-N'-ACYLHYDRAZINES | UBE INDUSTRIES, LTD. (JA) | 1977-10-04 | — | — | US | disclosed |
| US-4043976-A | N,N'-DIBENZOYLHYDRAZINE DERIVATIVE | UBE INDUSTRIES, LTD. (JA) | 1977-08-23 | — | — | US | disclosed |
| US-4043976-A | N,N'-DIBENZOYLHYDRAZINE DERIVATIVE | UBE INDUSTRIES, LTD. (JA) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109818-A1 | LIQUID SILICONE RUBBER COMPOSITION | MCM5, H1-5, HNRNPH3 | RAB9A 3232/4885NPC1 2852/4885CTDSP1 876/4885 |
| US-20260098144-A1 | RESIN COMPOSITION, FILM WITH RESIN, PREPREG, SHEET OF METAL FOIL WITH RESIN, METAL-CLAD LAMINATE, AND PRINTED WIRING BOARD | ATP1A4, ATP4B, ATP1B3 | RAB9A 2144/4885NPC1 2834/4885CTDSP1 2716/4885 |
| US-20260138359-A1 | SILICONE-THERMOPLASTIC COMPOSITE ARTICLES | MLST8, MCM7, RPL23 | RAB9A 4663/4885NPC1 4346/4885CTDSP1 2017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.